The Invesco Pharmaceuticals ETF (PJP) was launched on 06/23/2005, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market. What Are ...

The third-quarter results of the broader Medical sector, which includes major large-cap pharmaceutical companies, have been quite impressive this year, with more than 82% of sector participants having ...

VanEck Pharmaceutical ETF offers focused exposure to large-cap pharmaceutical companies, benefiting from strong long-term demographic and innovation trends. PPH's high concentration in top holdings ...

Pharmaceutical shares just witnessed their strongest week in 23 years, thanks to Pfizer's PFE major drug-pricing and tariff deal with the U.S. government that helped ease long-standing pressures on ...

The VanEck Pharmaceutical exchange-traded fund is on a strong run this week as news of Pfizer's deal with the Trump administration helped boost pharmaceutical stocks. The ETF was up 1.1% at $94.36 in ...

Global drug stocks rally as the FDA names Richard Pazdur, its top cancer drug regulator, as the head of its influential ...

Imagine this: a hospital conference room, lights low, filled with decision-makers. A sales representative clicks through slides driven by Palantir Technologies’ (NASDAQ:PLTR) Foundry platform, ...

It appears the pharmaceutical industry may avoid threatened tariffs. An exchange-traded fund (ETF) is a great way to invest in major drugmakers. Now may be the time to invest in drug companies, as ...

Biopharma has finally begun catching up with the overall stock market, as shares of the top three biopharma exchange traded funds (ETFs) jumped well into double digits over the past six months.

iShares Biotechnology ETF (IBB) offers targeted exposure to the U.S. biotechnology sector, providing investors with access to a broad basket of industry-leading biotech equities. The fund's strategy ...